Europe · Regional markets · Anadolu Agency Arabic (Economy)
Personalized cancer vaccine cuts risk of melanoma recurrence or death by 42% in trial
Researchers say findings could represent significant step toward personalized cancer treatment aiming to stimulate immune system to remaining cancer cells after surgery | Anadolu…
Read the full article on Anadolu Agency Arabic (Economy) Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.aa.com.tr)




